CD34 and graft versus host disease: They found that mice receiving CD34+mono were less likely to develop GVHD in an allogeneic transplant model, and concluded that CD34+mono-derived NO would regulate the allogeneic response by T-cell apoptosis with a subsequent induction of regulatory T-cells (Treg)12.